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Summary
Sudden cardiac death (SCD) during sport is frequently the first and the last 
manifestation of an unrecognised, underlying, often asymptomatic heart 
disease. Athletes are seen as one of the healthiest segments of the popu-
lation. SCD in an athlete is always shocking and profoundly affects the 
communities where it occurs. As a result of the considerable media atten-
tion that often accompanies SCD in an athlete, it has been suggested that 
its prevalence is overestimated. However, in reality the incidence may still 
be higher than we think as SCD events occurring during recreational-lei-
sure sports may be underreported. An overall incidence of 1:50 000 ath-
letes per year is a reasonable estimate based on available retrospective 
cohort studies and prospective observational or cross-sectional studies 
with male black basketball athletes being at higher risk (1:11 000 athletes 
per year).
Overall the health benefits of regular exercise heavily outweigh the risks 
of SCD in young and in older athletes, especially in those who train appro-
priately. This is “the paradox of sports”: physicians are faced with the chal-
lenge of providing a sensible strategy for the prevention of SCD while 
simul taneously reaffirming that the benefits of regular exercise far out-
weigh potential risks. Considering the potentially increased, albeit small, 
risk of cardiac events and SCD during physical activity (PA), it is prudent to 
establish practical and pragmatic algorithms for the cardiovascular evalu-
ation of young and of middle-aged / senior individuals before engaging in 
regular PA.
However, there is disagreement on how to implement an effective pre- 
participation screening strategy of SCD prevention in athletes, which is, at 
the same time, cost-effective. At present there is a broad range of screen-
ing recommendations, which vary from country to country.
In this brief review, we summarise the current state of knowledge in this 
area with respect to epidemiology, mechanisms, approaches to risk strat-
ification based on existing scientific evidence and on expert documents.
Screening for SCD prevention in athletes by cardiology/sport physicians in 
Switzerland will then be discussed.
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Epidemiology
Sudden cardiac death (SCD) in athletes is a rare event 
(1–2 / 100 000 / year) [1, 2], with an incidence that varies 
depending on age, sex and intensity of sports activity. 
The true incidence of SCD in athletes is widely debated.
Differences in current estimates of the incidence are 
largely due to differing methodology and heterogene-
ous population comparisons. Several factors affect 
case identification including the definition of an ath-
lete, methods of data acquisition, too broad age ranges 
of the population,  poorly defined examined popula-
tion, SCD only during sport or at any time, lack of man-
datory reporting requirements, inclusion or not of 
sudden cardiac arrest (SCA) survivors and absence of 
standardised autopsy protocols [1].
In well-defined age subgroups, such as athletes aged 
14–18 years, estimates of SCD/SCA annual incidence 
range from 1:50 000 to 1:80 000. High-risk subgroups 
identified include men (1:41 000) and male basketball 
athletes (1:33 000) [2]. Estimate of the SCD/SCA annual 
rate for athletes aged 17–24 years is 1:43 000 overall, 
with high-risk subgroups identified as men (1:33 000), 
African-Americans (1:18 000), male black basketball 
athletes (1:11 000) and Division I male black basketball 
athletes (1:3000) [3]. While athletes aged between 12 
and 35 years present an estimated incidence of SCD of 
1:47 000 [4], in athletes aged 36–49 years estimates of 
SCD incidence reach 1:15 000 for competitive sports 
and 1:34 000 for noncompetitive sports [5]. Further-
more, SCD may be higher in some athletes (male, black, 
basketball player).
List of abbreviations:
CAD: coronary artery disease
SCD: sudden cardiac death
SCA: sudden cardiac arrest
ARVC: arrhythmogenic right ventricular cardiomyopathy
HCM: hypertrophic cardiomyopathy
METS: metabolic equivalents
PA: physical activity
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Classification of sports activities
Physical activity (PA) is defined as any bodily move-
ment produced by skeletal muscles that results in en-
ergy expenditure beyond resting metabolism. The vol-
ume of PA (i.e., total energy expended) is expressed in 
metabolic equivalents or METS. One MET equals the 
resting metabolic rate of 3.5 ml O2/kg/min. The total 
volume of habitual PA level (volume = intensity × dura-
tion = METS × duration or MET-h/week) is a marker to 
discriminate low, moderate and high intensity activity. 
According to these considerations, sports activities can 
be classified according to the type and intensity of ex-
ercise performed [6]. There are two broad types of exer-
cise, dynamic (isotonic) and static (isometric), on the 
basis of the mechanical action of the muscles involved. 
Dynamic exercise can be divided into low, moderate 
and high intensity depending on the METS. High-in-
tensity PA is defined as PA >6 METS [6]. Static exercise 
can be divided into low, moderate, and high intensity 
on the basis of the estimated percent of maximal vol-
untary muscle contraction. The cardiovascular de-
mands of very high-resistance dy nam ic exercise (en-
durance) are similar to high-sustained static exercise 
(power) and this is important because high  intensity 
PA is associated with an increased risk for cardiac 
events in individuals harbouring cardiovascular dis-
ease [7–9]. High-intensity dynamic sports are running, 
swimming, basketball, football, cycling, rowing, ten-
nis, hockey, etc. High-intensity static sports are mar-
tial arts, sport climbing, weight lifting, etc. [6].
Classification of athletes
It is important to differentiate between young and 
middle-age/senior individuals engaged in PA. To com-
ply with the majority of cardiovascular literature, we 
are using the cut-off point of 35 years [10]. The inci-
dence rate of SCD in sports is 4–5 times higher in older 
age groups (>35 years, e.g., master athletes) compared 
with athletes of a younger age (≤35 years) [11]. Athletes 
should be defined according to the type, frequency, 
dura tion and intensity of sport participation and cate-
gorised into “competitive” or “recreational” [12]. Com-
petitive athletes are defined as individuals who are en-
gaged in exercise training on a regular basis and 
participate in official sports competitions. Usually, 
they exercise >10 h per week. Recreational athletes are 
defined as individuals engaged in recreational or lei-
sure-time sports activities, on either a regular basis or 
intermittently. Usually, they exercise <10 h per week. 
Recreational sports do not necessarily require system-
atic training or the pursuit of excellence, nor do they 
convey the same pressure to prevail against others [12].
Based on the above-mentioned description, we aim to 
divide athletes into:
1. Young athletes <35 years;
2. Middle-aged/older athletes ≥35 years.
And then stratified based on type, frequency, duration 
and intensity of sport activities:
a) Recreational athletes engaged in low–moderate in-
tensity sports (METS <6);
b) Recreational athletes engaged in high-intensity 
sports (METS >6);
c) Competitive athletes;
d) Elite level (professional and semi-professional).
Cause and pathogenesis of sudden death 
during sports
The well-known beneficial effects of aerobic exercise 
[13, 14] are partly mediated through modification of 
several risk factors for coronary artery disease, includ-
ing components of the metabolic syndrome and effects 
on endothelial dysfunction and blood coagulation [15]. 
During sport activities, depending on the type of exer-
cise (dynamic versus static), the stroke volume in-
creases up to 70%, heart rate increases 3 to 4 times 
compared with the resting state, thus decreasing ven-
tricular filling owing to diastolic shortening, while sys-
tolic blood pressure may increase beyond 200 mm Hg. 
In response to the growing needs of the heart, struc-
tural and electrical adaptive changes occur in the heart 
of the athlete, referred to as the athlete’s heart. This car-
diac remodelling consists of alterations in ventricular 
chamber dimensions, including increased left and 
right ventricular and left atrial cavity size. The dimen-
sions of the athlete’s heart rarely exceed the upper lim-
its of normal, if adjusted for body size [16], but occa-
sionally there may be a relatively mild increase in 
absolute left ventricular (LV) wall thickness (mostly ec-
centric hypertrophy) that exceeds upper normal lim-
its. Recently, it has been shown that physical exercise 
determines cardiac growth also through new cardio-
myocyte formation [17, 18]. The LV remodelling with 
changes in mass is dynamic in nature and may appear 
to develop relatively rapidly, or more gradually, after 
the initiation of vigorous conditioning and is reversi-
ble with cessation of training [19]. 
While the haemodynamic stress produced by exercise 
is well tolerated by a trained, healthy heart, during vi-
gorous PA (defined as PA >6 METS), electrical instability 
may be produced in subjects with predisposing, un-
identified cardiac conditions (table 1). This represents 
the paradox of sports. In athletes younger than 35 ye-
ars, underlying hereditary or congenital cardiovascu-
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lar abnormalities may be present, such as hyper trophic 
cardiomyopathy, coronary artery disease abnor mality, 
accessory atrioventricular pathway, chanellopathy, or 
arrhythmogenic right ventricular cardiomyopathy. 
 Given the different substrates involved in younger pa-
tients, the underlying mechanisms determining SCD 
in the younger patient group are heterogenous, involv-
ing a purely electrical mechanism in a structurally 
normal heart (this is the case in Brugada syndrome or 
pre-excited atrial fibrillation), or, in other cases, a dis-
eased myocardial substrate as is the case in hyper-
trophic cardiomyopathy (HCM) or arrhythmogenic 
right ventricular cardiomyopathy (ARVC). In athletes 
older than 35 years of age, coronary heart disease is the 
main heart disease associated with SCD in sports. In 
these subjects, during vigorous exercise there are two 
phases of electrical vulnerability in which malignant 
ventricular arrhythmias may be initiated: the first dur-
ing peak exercise; the second during the immediate re-
covery phase [20]. At peak exercise, increased circulat-
ing catecholamines cause heart rate and blood 
pressure increases as well as favouring adhesion of 
platelets, hence producing increasing wall stress to the 
vessels, especially coronaries, resulting in possible cor-
onary spasm or atherosclerotic plaque disruption [21]. 
Transient or prolonged myocardial ischaemia may de-
velop and modify cardiomyocyte physiochemical 
properties by producing sodium-potassium shifts, 
which alter cell depolarisation and repolarisation as 
well as conduction velocity. At the electrophysiological 
level, electrical instability finds expression through in-
creased ventri cular ectopic activity with nonsustained 
or sustained tachyarrhythmias, which may degenerate 
into ventricular fibrillation. In the recovery phase, my-
ocardial ischaemia is also thought to be the resulting 
trigger, which, however, develops as a result of the sud-
den drop of venous return and cardiac output follow-
ing abrupt cessation of PA [7] (table 1).
Preparticipation screening strategy
Preparticipation screening offers the possibility to 
identify athletes with potentially lethal cardiovascular 
abnormalities early on and to protect them from the 
risk of sports activity. Although there is universal 
agreement that preparticipation screening should be 
performed in athletes, there is an international debate 
surrounding the optimal screening strategy. At the 
present time, there is a broad range of screening rec-
ommendations, which vary between countries, sport-
ing discipline, and level of competition. Such tests are 
endorsed by various sports and medical groups, in-
cluding the European Society of Cardiology [22], the 
Inter national Olympic Committee, Fédération Inter-
nationale de Football Association (FIFA) and many pro-
fessional US sporting organisations. While there is 
overall agreement that the subject’s history, as well as 
a physical examination, are essential, there is ongoing 
debate on the role of the 12-lead ECG. Interpretation of 
the 12-lead ECG of an athlete may be difficult because of 
training-induced dynamic alterations. This accounted, 
in the past, for a high rate of false positives (i.e., ath-
letes with ECG abnormalities but with a normal heart), 
as demonstrated by the analysis of the long-term Ital-
ian mass-screening programme; this finding raised 
the problem of better defining the spectrum of ath-
letes’ ECG abnormalities, with differentiation of physi-
ological ECG changes from pathological ECG ab-
normalities [23]. The most common training-induced 
“normal” asymptomatic ECG alterations are nowadays 
considered to be [24]:
– Sinus bradycardia (≥30 bpm);
– Sinus arrhythmia;
– Ectopic atrial rhythm;
– Junctional escape rhythm;
– First-degree atrioventricular block (PR interval >200 
msec);
– Incomplete right bundle-branch block;
– Isolated QRS voltage criteria for left ventricular 
hyper trophy;
– Early repolarisation (ST elevation, J-point elevation, 
J-waves or terminal QRS slurring);
– Convex (“domed”) ST segment elevation combined 
with T-wave inversion in leads V1–V4 in black / Afri-
can athletes.
Table 1: Causes of sudden death.
Structural or functional abnormalities
Hypertrophic cardiomyopathy
Arrhythmogenic right ventricular cardiomyopathy / dysplasia
Coronary artery abnormalities
Marfan syndrome with aortic dissection
Valvular disease
Dilated cardiomyopathy
Channelopathies and electrical diseases
Accessory pathway-mediated tachycardia  
Wolff-Parkinson-White
Long QT syndrome
Short QT syndrome
Brugada syndrome
Primary / idiopathic ventricular tachycardia / fibrillation
Acquired
Commotio cordis
Atherosclerotic coronary artery disease
Drug abuse
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The lack of prospective data validating the use of the 
12- lead ECG to prevent SCD in sports has, however, lim-
ited diffusion of the 12-lead ECG for preparticipation 
screening in certain countries and regions. In 1997, a 
mandatory preparticipation screening programme 
was implemented in Israel. By law, the obligatory 
screening tests for all athletes include a medical ques-
tionnaire, physical examination, baseline ECG and ex-
ercise stress testing. A study compared the 12 years be-
fore screening with the 12 years after the onset of 
mandatory ECG screening to evaluate the incidence of 
SCD/SCA in athletes [25]. There was no apparent influ-
ence on the incidence of sudden death in athletes. 
However data on the effects of ECG screening on mor-
tality rates among athletes are observational and 
retro spective; in addition data were extrapolated to al-
low for the growth of the population available from Is-
raeli Bureau of Statistics to estimate the denominator 
for the number of person-years at risk. The study lim-
ited the analysis to competitive athletes and there was 
a 50% increase in the last 10 years of the sporting pop-
ulation. Because of the small number of events, it is 
possible that the observed nonsignificant difference is 
the result of a β-type error. Therefore there are many 
limitations, perhaps enough to explain these results.
Another study from Minnesota showed a low mortal-
ity rate in a population of athletes not undergoing sys-
tematic ECG screening [26]. In the USA, the lack of evi-
dence derived from pospective studies on large cohorts 
of athletes and the costs required to support a diffuse 
national screening strategy have placed the use of ECG 
for screening at a low level of recommendation (class 
IIb and level of evidence C) in the recently issued Scien-
tific Statement from the American Heart Association 
and the American College of Cardiology, for young 
healthy people aged 12 to 25 years of age [27].
The European counterpart, conversely, considers the 
12-lead ECG as central for appropriate preparticipation 
screening. This is mainly based on the favourable ex-
perience of certain regions that have applied a coordi-
nated and articulated screening strategy to prevent 
SCD through the use of the 12-lead ECG. In Veneto, Italy, 
for instance, preparticipation evaluation is required by 
law and a mass screening programme, essentially 
based on a 12-lead ECG, has been the practice for more 
than 30 years. A time-trend analysis of the incidence of 
SCD in young competitive athletes over 26 years (1979–
2004) showed a sharp decline (by 89%) of mortality 
rates after the introduction of the regional screening 
programme. Most of the reduction was attributable to 
fewer SCDs due to underlying HCM and ARVC [28]. This 
favourable experience brought about, in 2005, the re-
lease of a consensus statement of the Section of Sports 
Cardiology of the  European Society of Cardiology (ESC) 
proposing a common European screening protocol for 
prevention of SCD in young competitive athletes, 
which included an ECG in addition to history taking 
and physical examination. However, the document 
listed the ECG abnormalities relevant to preparticipa-
tion screening but did not provide any specific guide-
lines for interpretation of athlete’s ECG [29]. The percu-
liarity of the athlete’s ECG is that changes may be 
produced by training. These develop as a consequence 
of the heart’s adaptation to sustained physical exercise 
(athlete’s heart). Such physiological ECG changes may 
overlap with ECG abnormalities seen in cardiovascular 
diseases that cause SCD in the young [27, 30].
In fact, a new perspective on the interpretation of an 
athlete’s ECG was first proposed in 2010 by a consensus 
document of the ESC, with the aim to improve the ac-
curacy and cost-effectiveness of the use of the ECG for 
screening athletes for cardiovascular diseases [31]. In 
this document, the athlete’s ECG changes were classi-
fied into two groups: “common and training-related” 
(Group 1) and “uncommon and training-unrelated” 
(Group 2). Following the 2010 ESC document, a number 
of contributions have aimed to improve the accuracy 
of the ECG criteria. In 2011, a group of experts coordi-
nated by Dr. Froelicher of the Stanford University pub-
lished a second international consensus document, 
which provided clearer definitions and more stringent 
cut-off values for long QT interval and intraventricular 
conduction delay [32]. The criteria were further refined 
following a summit on “ECG Interpretation in Ath-
letes” held in  Seattle. The “Seattle criteria” document 
provided a detailed description of ECG parameters 
with reference values for abnormality [33]. The specific-
ity of this new criteria was compared in a series of 1 417 
healthy USA athletes and found that the rate of false 
positive ECG abnormalities requiring further evalua-
tion decreased when applying the Stanford (8%) or Se-
attle (6%) criteria compared with the ESC (26%) criteria 
[34]. In the same way, the contribution by Bessem et al. 
compared the ECG criteria outcome of the ESC recom-
mendations and the Seattle ECG criteria in young 
 athletes aged 10–19 years and also described better 
 accuracy of the Seattle criteria, mainly due to reclassi-
fication of the long QT cut-off value [35].
In 2014, the “refined criteria” of the Seattle criteria 
were published. These new criteria reclassified isolated 
findings including left and right atrial enlargement, 
left and right axis deviation, right ventricular hyper-
trophy (as per Sokolow-Lyon voltage criteria), and 
T-wave inversions confined to leads V1–V4 in black ath-
letes. These criteria significantly reduce the number of 
false positive ECGs in both elite Black and White ath-
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letes without compromising sensitivity [36]. Therefore, 
interpretation of the 12-lead ECG according to the most 
recent criteria has become highly sensitive (approxi-
mately 94%) and specific (94–96%).
Assessment of risk profile for coronary 
artery disease
Coronary artery disease is by far the most important 
cause of sports-associated SCD in middle aged athletes 
and, even younger athletes, an important cause of SCD. 
According to the recently published recommendations 
of the EACPR, risk evaluation should rely on the pres-
ence or absence of classical risk factors for CAD [10]. 
To evaluate the risk in middle-aged individuals, the 
 estimation of individual cardiovascular risk using the 
Syste matic Coronary Risk Evaluation (SCORE) chart, 
for Switzerland, a low-risk country [37] is advocated. 
The SCORE chart allows estimation of the absolute risk 
of athero sclerotic cardiovascular death within 10 years 
based on gender, age, total cholesterol level, systolic 
blood pressure and smoking status.
Where do we stand in Switzerland?
Since sport-associated SCD/SCA shows regional differ-
ences and varies widely with respect to underlying 
heart disease, sport, ethnicity and gender, national 
study / registers of SCD/SCA are necessary.
In Switzerland, a retrospective analysis that concerned 
only German-speaking cantons provided valuable in-
sight into the epidemiology of SCD in our country. In 
this study, the incidence of leisure sports-associated 
SCD in athletes from 10 to 39 years was as low as 0.21 / 
100 000 athletes per year, and competitive sports- 
associated SCD was 0.57 / 100 000 athletes per year [38]. 
As stated by the authors, because of its retrospective 
nature and because there was no standardised proto-
col for auto psy, some forms of cardiac arrest may have 
been misclassified. Nevertheless interesting, the 
above- mentioned study showed that coronary artery 
disease with 18 cases (35%) is the most common cause 
of death, and hypertrophic cardiomyopathy with 
seven cases (13%) the second most common cause. 
Other causes include sudden unexplained death (SUD), 
aortic dissection, valvular disease and dilated cardio-
myopathy. Of the 52 sport-associated SCDs, even if the 
prevalence of HCM and ARCV seems to be relatively 
low, potentially 16 (31%) would have been prevented by 
a resting ECG screening. Therefore CAD represents the 
most common causes of SCD/SCA even in younger ath-
letes, and this is also confirmed in a retrospective 
study in Norway where adults aged between 15 and 34 
years during the period 1990–1997 were examined [39]. 
The number of myocardial infarctions was higher than 
expected and was the most common cause of sudden 
death. Acute myocardial infarction with plaque rup-
ture in young athletes may be associated with heredi-
tary disorders of lipid metabolism. These data suggest 
that, even in athletes under 35 years of age, it would be 
useful to consider adding to the screening protocol 
measurement of the lipid profile in young athletes 
with family history of premature CAD, severe hyper-
cholesterolaemia or diabetes.
In 1998, the Swiss Society of Sports Medicine (SGSM) 
published one of the first official international recom-
mendations to prevent SCD. It was updated in 2011 [40]. 
Currently, the SGSM recommends that all competitive 
athletes, particularly team athletes, undergo a medical 
examination including a resting ECG from the age of 
14; this should be performed every one to two years un-
til cessation of competitive activity. For recreational 
athletes in Switzerland at the present time there is no 
nationwide screening recommendation. The establish-
ment of regular cardiac screening examinations re-
mains anyway difficult. There is a broad range of 
screening recommendations dependent upon region, 
sporting discipline, and competition level. Actually, 
only selected elite athletes are being screened, particu-
larly those from larger national sports federations, 
such as ice hockey, football, cycling and ski associa-
tions, which have formulated their own adapted rec-
ommendations for their professional athletes. Other-
wise preventive examinations are still poorly defined.
Based on the study of Notz, Lüscher and Schmied [41]
only 9% of the Swiss athletes (aged 13–35) had under-
gone preparticipation screening in their sports career 
previously and only 47% of the athletes were willing to 
undergo a preparticipation screening. Therefore, ad-
herence to these screening initiatives also appears to 
be an important issue.
As far as costs are concerned, in Switzerland the federal 
law on prevention and health promotion regulates the 
introduction of management tools and coordination, 
as well as financing. As there is no clear law on the 
financ ing of prevention, in principle, the costs must be 
supported by the sport organism or by individual ath-
letes. In recent years, two prospective studies of Mena-
foglio et al. examined costs, workload and yield of pre-
participation cardiovascular screening in young and 
middle-aged individuals engaged in high-intensity 
sport activities in Switzerland [42, 43]. For younger ath-
letes, examined according to the ESC 2005 protocol 
with modern ECG criteria, 6.3% required further exam-
inations, including 3.9% because of abnormal ECG find-
ings. In 1.0% diagnosis of a previously unknown car-
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diac abnormality was established and four athletes 
(0.4%) presented cardiovascular alterations that could 
have potentially caused cardiac arrest. The basic costs 
of the screening protocol was 102.80 CHF per athlete 
and the mean cost per athlete including second-line 
cardiac examinations was 147 CHF. Regarding mid-
dle-aged athletes, 14.3% required additional examina-
tions; in 5.1% this was motivated by abnormal ECG find-
ings, examined according the 2011 EACPR protocol. In 
2.8% of cases, diagnosis of a new cardiovascular abnor-
mality was established; 0.4% of athletes were consid-
ered not eligible for high-intensity sports. In this sub-
group of athletes, the cost of the baseline evaluation 
was 117 CHF per athlete and the mean cost per athlete 
was 179 CHF including second-line cardiac examina-
tions.
These studies state that: 1) cardiovascular preparticipa-
tion examination with an ECG recording in young ath-
letes and cardiovascular evaluation in middle-aged in-
dividuals engaged in high-intensity sports following 
the  EACPR protocol is feasible in Switzerland at reason-
able cost; 2) using modern and  selective criteria for in-
terpreting the ECG (developed for young athletes), the 
rate of abnormal ECGs is low even in the middle-aged 
group; 3) the ECG plays a key role in detecting serious 
cardiac disease. Therefore, according to the above-men-
tioned studies, the cost of pre participation screening 
in Switzerland seems reason able.
Reccommendations for preparticipation 
screening in Switzerland
The aim of preparticipation screening is to identify 
athletes with previously undetected, asymptomatic 
underlying heart or vascular disease in order to pre-
vent SCD/SCA during sports [10, 29]. Given the impor-
tance of the personal history and the family history of 
cardiovascular diseases, physicians should systemati-
cally perform clinical examinations aimed at identify-
ing suspicious information in the family or clinical 
history of the athlete. For this the use of  the “Lausanne 
Recommendations” is recommend.
Key elements to identify in the younger (<35 years) sub-
ject’s history include family history for cardiomyo-
pathies such as HCM, ARVC or channelopathies [44, 45] 
(table 1). In subjects over 35 years of age, particular im-
portance should be given to establishing the patient’s 
cardiovascular risk and family history of CAD. In all 
athletes evaluated in the scheme of a preparticipation 
visit, particular attention should be addressed towards 
the identification of relevant symptoms including pal-
pitations, chest discomfort during exertion, and espe-
cially presyncope or syncope. Important physical find-
ings include cardiac or vessel murmurs, unusually 
high resting heart rate or blood pressure. Several stud-
ies have shown that athletes who were victims of SCD 
had premonitory symptoms, such as syncope, or a pos-
itive family history for SCD [46].
The proposal for a cut-off of 35 years for athlete groups 
is internationally accepted. Preparticipation screening 
is recommended for athletes who practice or who in-
tend to initiate high-intensity PA. Individuals who wish 
to engage in low to moderate intensity PA (<6 METS) are 
considered eligible without further evaluation.
Considering what has been discussed above, taking 
into account the consensus statement of sports car-
diology section of ESC, the “2011 AHA/ACC scientific 
statement on ECG screening”, the incidence on SCD in 
Switzerland, and the studies carried out on athletes in 
Switzerland with implications for workload, yield and 
economic cost, for the Swiss reality, the following spe-
cific recommendations for a screening protocol could 
be proposed:
Figure 1: Preparticipation screening in young athletes <35 years. Adapted from: Borjes-
son M, Urhausen A, Kouidi E, Dugmore D, Sharma S, et al. Cardiovascular evaluation of 
middle-aged / senior individuals engaged in leisure-time sport activities: position stand 
from the sections of exercise physiology and sports cardiology of the European Associ-
ation of Cardiovascular Prevention and Rehabilitation. Eur J Cardiovasc Prev Rehabil. 
2011;18(3):446–58.
Young athletes
<35 years
Athletes engaged in high-activity 
insensity (>6 METS), competitive athletes, 
elite athletes
Personal history
Family history of cardiovascular diseases
Physical exam
Consider blood samples if family history of premature
CAD or severe hypercholesterolemia or diabetes
rest ECG
normal abnormal
Eligible for high-
intensity exercise
Further evaluation,
appropriate treatment
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1. Preparticipation screening in young athletes <35 
years (fig. 1):
– personal history (positive in the case of exertional 
chest pain or discomfort, syncope or near-syncope, 
irregular heartbeat or palpitations, in the presence 
of shortness of breath, or fatigue disproportionate 
to the degree of physical effort);
– family history of cardiovascular diseases (positive 
when close relatives had experienced a premature 
heart attack or sudden death, below 55 years of age 
in males and 65 years in females, or suffered from 
cardiomyopathy, Marfan syndrome, long QT syn-
drome, Brugada syndrome, severe arrhythmias, 
coronary artery disease, or other disabling cardio-
vascular diseases);
– physical examination related to cardiovascular dis-
eases (positive in presence of musculoskeletal and 
ocular features suggestive of Marfan syndrome, di-
minished and delayed femoral artery pulses, mid- or 
end-systolic clicks, a second heart sound single or 
widely split and fixed with respiration, marked heart 
murmurs [any diastolic and systolic murmur grade 
>2/6], irregular heart rhythm and brachial blood 
pressure above 140/90 mm Hg in resting conditions 
[on more than 1 reading] and inter-arm systolic 
blood pressure difference above 10 mm Hg [25]);
– (blood samples) consider determining cholesterol/
glucose levels in young athletes with a family his-
tory of premature CAD, severe hypercholesterolae-
mia or diabetes;
– resting 12-lead ECG (following the new ECG “Seattle 
criteria”);
– if abnormal screening (abnormal medical history, 
physical examination or ECG findings), it is neces-
Middle-aged / older
athletes ≥35 years
Recreational athletes engaged in high-activity
intensity (>6 METS), competitive athletes,
elite athletes
History
Physical exam
Rest ECG
Blood samples
Assessment of risk profile for CAD
(SCORE chart)
negative
negative
positive
positive
Eligible for high-
intensity exercise
Further evaluation,
appropriate treatment
Maximal exercise
testing
Figure 2: Pre-participation screening in middle-aged / older athletes ≥35 years. Adapted from: Borjesson M, Urhausen A,  
Kouidi E, Dugmore D, Sharma S, et al. Cardiovascular evaluation of middle-aged / senior individuals engaged in leisure-time 
sport  activities: position stand from the sections of exercise physiology and sports cardiology of the European Association  
of  Cardiovascular Prevention and Rehabilitation. Eur J Cardiovasc Prev Rehabil. 2011;18(3):446–58.
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sary to perform further examinations according to 
the recommendations for evaluating athletes with 
cardiovascular abnormalities [29, 45].
2. Preparticipation screening in middle-aged / older 
athletes aged ≥35 years, recreational athletes en-
gaged in high-activity intensity (>6 METS), competi-
tive athletes, elite athletes (fig. 2):
– family history;
– personal history;
– physical examination;
– blood samples (to evaluate the total cholesterol and 
glucose levels);
– resting ECG;
– assessment of risk profile for CAD based on risk fac-
tors (SCORE chart, importance of single risk factors).
If high risk then
– maximal exercise testing.
If negative → eligible for high-intensity activity;
if positive then further examinations to confirm or 
exclude an underlying cardiac disease, according to 
the recommendations for evaluation of athletes with 
cardiovascular abnormalities [25, 45].
Conclusion
Although the risk of SCD/SCA among athletes is re-
ported to be rather low across studies, this risk is likely 
to be underestimated because it is based on retrospec-
tive data. In order to obtain accurate data on SCD in 
athletes, a prospective, complete, mandatory report-
ing system of all cardiac arrest events is necessary with 
a reliable population of referral as the denominator.
Although the role of the ECG for screening remains 
controversial because of high false positive rates, 
which require additional cardiac examinations, over 
recent years several efforts have been made to refine 
the original ESC criteria (the “refined Seattle criteria”) 
and soon there will be other new ECG criteria for inter-
pretation of the athlete’s ECG in order to improve spec-
ificity without compromising its sensitivity.
Based on the most recent literature on SCD incidence, 
cause of SCD and economic aspects, the moment has 
arrived to implement more advanced cardiac screen-
ing, with a prespecified protocol of medical screening 
as that described in this text, in young competitive 
athletes and in middle-aged athletes engaged in 
high-intensity activities, to identify life-threatening 
conditions for the purpose of minimising the risk as-
sociated with the interaction between sports and car-
diovascular disease.
Healthcare systems have a responsibility to recom-
mend increased PA by minimising risks and maximis-
ing benefits. Keeping in mind that the primary aim of 
the screening programme is to save athletes’ lives 
rather than money, the economic concern is always 
delicate. However, as we have seen, the costs for the 
baseline evaluation as well as for the additional sec-
ond-line cardiac examinations seem reasonable. Final-
 ly, as cardiovascular screening will never be able to 
identify all athletes at risk, for secondary prevention, 
adequate preparation is vital in case of a potentially 
fat al event at the sporting arena / facility.
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